immunodiagnosticsystems
0
immunodiagnosticsystems
0
  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    Hypertension
    CKD-MBD
    Growth
    Cartilage Markers
    Fertility
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • Investor Relations
  • Contact
immunodiagnosticsystems
+44 (0)191 5190660
0

Quotes

  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    Hypertension
    CKD-MBD
    Growth
    Cartilage Markers
    Fertility
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • Investor Relations
  • Contact

Month: October 2010

  • All News
  • Company News
  • Event News
  • Industry News
  • Product News
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 MARCH 2011

Notification of Major Interests in Shares October 2010

Notifications of major interest in shares. Download Announcement

Finance

Posting of Report and Accounts and Notice of AGM

The Company confirms that the annual report and accounts for year ended 31 March 2010 have been posted to shareholders. Copies are available on the Company’s website: www3.idsplc.com.  

unnamed

IDS Trading Update September 2010

Immunodiagnostic Systems Holdings plc (“IDS” or “the Company”), a leading producer of diagnostic testing kits for the clinical and research markets, announces a trading update for the six month period to 30 September 2010, prior to the release of its half-yearly report on Tuesday, 30 November 2010. Turnover from continuing operations for the period is […]

  • About Us
  • Products
  • Instrumentation
  • Clinical Areas
  • Research Areas
  • Investor Relations
  • Contact
  • Disclaimer

Sign up for our Newsletter

Connect with us
Connect with us
Connect with us
  • Careers
  • News & Events
  • Sitemap
  • Cookie Policy
  • Terms of Use Policy
  • Privacy Policy
  • Acceptable Use Policy
IDS PLC © 2017 Immunodiagnostic Systems. All Rights Reserved. IDS is a listed company, traded on the Alternative Investment Market (AIM; trading symbol IDH) of the London Stock Exchange. Please note our sites uses cookies for content personalisation, please review our cookie policy for further information.

Sign up for our Newsletter

To receive our Newsletter Document Name, please provide us with your following details:

To receive our Newsletter, please provide us with your following details:

Close cookie popup

This website uses cookies: By continuing to browse this site you accept this policy.